|
|
|
Volumn 10, Issue 2, 2010, Pages 299-356
|
|
Can I tell you the truth? A comparative perspective on regulating off-label scientific and medical information.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENINE;
ANGIOGENESIS INHIBITOR;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
BENZHYDRYL DERIVATIVE;
BEVACIZUMAB;
BOTULINUM TOXIN A;
CENTRAL STIMULANT AGENT;
DRUG DERIVATIVE;
MODAFINIL;
MONOCLONAL ANTIBODY;
MUSCLE RELAXANT AGENT;
PHOSPHONIC ACID DERIVATIVE;
RANIBIZUMAB;
TENOFOVIR DISOPROXIL;
ARTICLE;
COMPARATIVE STUDY;
DRUG INDUSTRY;
DRUG LEGISLATION;
ETHICS;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
INTERPERSONAL COMMUNICATION;
LEGAL ASPECT;
MANAGEMENT;
MEDICAL ETHICS;
OFF LABEL DRUG USE;
POLICY;
TREATMENT OUTCOME;
UNITED KINGDOM;
UNITED STATES;
ADENINE;
ANGIOGENESIS INHIBITORS;
ANTI-HIV AGENTS;
ANTIBODIES, MONOCLONAL;
BENZHYDRYL COMPOUNDS;
BOTULINUM TOXIN TYPE A;
CENTRAL NERVOUS SYSTEM STIMULANTS;
DRUG INDUSTRY;
ETHICS, MEDICAL;
GREAT BRITAIN;
HUMANS;
LEGISLATION, DRUG;
NEUROMUSCULAR AGENTS;
OFF-LABEL USE;
PHOSPHONIC ACIDS;
POLICY MAKING;
PUBLIC POLICY;
TREATMENT OUTCOME;
TRUTH DISCLOSURE;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 77955958630
PISSN: 15353532
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (23)
|
|
References (0)
|
